Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

News

Webinar, Dec. 15: How to Measure Success -- Improving Our National HIV Prevention Indicators

December 8, 2016

Join us on Dec. 15 for a webinar with Treatment Action Group:

How to Measure Success: Improving Our National HIV Prevention Indicators
Thursday, Dec. 15
3:30 - 5 p.m. ET; 2:30 - 4 p.m. CT; 1:30 - 2 p.m. MT; 12:30 - 1 p.m. PT

Register today!

The first goal of the National HIV/AIDS Strategy (NHAS) is to "reduce new infections." In order to monitor progress toward this goal, the Centers for Disease Control and Prevention (CDC) and the Office of National AIDS Policy will be looking at three chosen "indicators" leading up to 2020:

  1. Increase the percentage of people living with HIV who know their serostatus to at least 90%.
  2. Reduce the number of new diagnoses by at least 25%.
  3. Reduce the percentage of young gay and bisexual men who have engaged in HIV-risk behaviors by at least 10%.

Some national HIV prevention advocates question if these are the right national indicators to monitor progress on reducing new infections. In 2015, the CDC and Office of National AIDS Policy changed the way in which we monitor progress toward this goal by switching from incidence estimates to using new diagnoses. Are diagnoses really measuring the number of people being infected each year? Should changing sexual behavior still be a primary indicator in NHAS? Where is PrEP? What about more structural indicators?

Please join Treatment Action Group and HIV PJA on Thursday, Dec. 15 as we host an online discussion about other possibilities for monitoring progress and what community advocates and other key stakeholders need to know about how we measure success in our national HIV prevention efforts.

Panelists include:

  • Keri N Althoff, Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
  • Denis Nash, PhD, MPH, City University of New York (CUNY); Executive Director, CUNY Institute for Implementation Science in Population Health (ISPH); Professor of Epidemiology, CUNY School of Public Health
  • Stefan Baral, Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Register now!


Related Stories

Protect Our Communities! Share Your Concerns With Gilead About Their New Prevention Trial
Health Care at Risk
More Calls to Action



This article was provided by HIV Prevention Justice Alliance. Visit HIV Prevention Justice Alliance's website to find out more about their activities and publications.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.